In a pandemic the pharmaceutical industry is hailed as a saviour; yet the industry is using the crisis to lock in its problematic, profit-maximising model. Pushing for public money with no-strings-attached, and stronger monopoly patent rules, the industry’s wish-list could restrict access to COVID-19 drugs and vaccines, prolonging the pandemic in the name of profit. Control over prices and access must not be left in private hands: health is a human right.
Related Articles

Corruption
Richard Brooks: The financial scandal no one is talking about
May 29, 2018
Mathew D. Rose
Corruption, Finance, Financial Institutions, Monopolies, Regulatory Capture, Revolving Door
0
This article features extracts from Richard Brook’s new book, Bean Counters: The Triumph of the Accountants and How They Broke Capitalism. Read here See our review of the book here

Finance
telesur: Neoliberal Argentina Bans NGOs From WTO Summit in Last-Minute ‘Unprecedented’ Move
If you can’t beat them (not in the literal sense as was the case at the G-20 in Germany recently), then forbid them Read here

Austerity
Serge Halimi: Forgotten France rises up
January 10, 2019
Mathew D. Rose
Austerity, Corruption, Economics, EU politics, Finance, Inequality, National Politics, Neo-Liberalism in the EU, Political Parties, Tax
0
A brilliant article. Le Monde diplomatique at its best. The social reality Halimi describes could be the UK. Also the forces protecting neo-liberalism: Graduates, the middle class, those in big cities, the EU ‘Journalists must […]
Be the first to comment